01 1Olon S. p. A.
01 1Cefazolin acid
01 1Italy
Registration Number : 219MF10322
Registrant's Address : Strada Rivoltana Km 6/7 20090 Rodano Milano Italy
Initial Date of Registration : 2007-10-24
Latest Date of Registration : 2020-01-17
39
PharmaCompass offers a list of Cefazolin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Cefazolin manufacturer or Cefazolin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cefazolin manufacturer or Cefazolin supplier.
A Gramaxin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Gramaxin, including repackagers and relabelers. The FDA regulates Gramaxin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Gramaxin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Gramaxin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Gramaxin supplier is an individual or a company that provides Gramaxin active pharmaceutical ingredient (API) or Gramaxin finished formulations upon request. The Gramaxin suppliers may include Gramaxin API manufacturers, exporters, distributors and traders.
click here to find a list of Gramaxin suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Gramaxin Drug Master File in Japan (Gramaxin JDMF) empowers Gramaxin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Gramaxin JDMF during the approval evaluation for pharmaceutical products. At the time of Gramaxin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Gramaxin suppliers with JDMF on PharmaCompass.
